Tuesday, December 02, 2014 9:26:25 AM
We have more complex trading schemes today than we had in your grandfathers market. That being so, the actions can be pretty
much impenetrable without doing some really deep dd. It's really
tedious work, tracing through all the SEC filings and then tracing
every name and company mentioned in there until one can come to
some definitive conclusions based on all of that data.
Hardly a wonder that most people take the short route, imagining
what the technology could do and scanning the balance sheets and
charts. Then holding all of that up against the kind of performance
one could expect of the industry over a longer term. Short term
thinking doesn't work very well here in these kinds of situations.
Since that kind of thinking would have had one selling out of
Amazon, Tesla, Google and just about any other high flyer, either
before they took off or while they were making their run.
We've made, what is essentially, a bet on the future and the future
is a longer way off than just a quarter or two. So, while day to
day performance may seem distressing for some, it really means
very little in the scheme of things to come. Like my friend told
me this morning: "Buy and buy big... I wanna make a million bucks!"
LOL
Happy investing all.
Recent DDD News
- 3D Systems Announces FDA Clearance for World’s First 3D-Printed PEEK Cranial Implants • GlobeNewswire Inc. • 04/15/2024 12:30:00 PM
- 3D Systems Receives NYSE Notice Regarding Late Form 10-K Filing • GlobeNewswire Inc. • 03/22/2024 12:00:00 PM
- Wilting Expands Production Capacity with Three DMP Flex 350 Printers • GlobeNewswire Inc. • 03/12/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 12:00:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 01:14:53 PM
- 3D Systems Announces Additional Partial Repurchase of Convertible Senior Notes • GlobeNewswire Inc. • 03/05/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 11:06:41 AM
- 3D Systems Reports Fourth Quarter and Full Year 2023 Financial Results (Unaudited) • GlobeNewswire Inc. • 02/27/2024 11:15:41 PM
- 3D Systems Introduces Industry’s First Multi-material, One-piece Jetted Denture Solution • GlobeNewswire Inc. • 02/21/2024 09:05:00 PM
- 3D Systems Announces Date of Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 02/14/2024 09:28:07 PM
- Systemic Bio to Present Innovative Human-relevant Datasets from h-VIOS™ Platform at SOT and AACR 2024 Annual Meetings • GlobeNewswire Inc. • 02/08/2024 01:30:00 PM
- WeAreAM Adds DMP Flex 350 Dual to Manufacturing Workflow — Expanding Addressable Applications • GlobeNewswire Inc. • 01/29/2024 01:30:00 PM
- 3D Systems Announces Executive Leadership Changes • GlobeNewswire Inc. • 01/10/2024 02:00:00 PM
- 3D Systems to Attend 26th Annual Needham Growth Conference • GlobeNewswire Inc. • 01/08/2024 09:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 09:15:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/14/2023 09:12:53 PM
- 3D Systems Announces Organization Changes and New Executive Leadership Appointments • GlobeNewswire Inc. • 12/13/2023 10:57:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 09:32:26 PM
- 3D Systems Announces Partial Repurchase of Convertible Senior Notes • GlobeNewswire Inc. • 12/06/2023 09:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/06/2023 08:11:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 09:13:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/29/2023 09:09:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:44:05 PM
- 3D Systems Receives FDA Clearance for NextDent® Base • GlobeNewswire Inc. • 11/15/2023 01:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:10:59 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM